Certara (NASDAQ:CERT) Rating Increased to Overweight at KeyCorp

KeyCorp upgraded shares of Certara (NASDAQ:CERT) from a sector weight rating to an overweight rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has $23.00 price target on the stock.

Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group upped their target price on Certara from $14.00 to $15.50 and gave the stock a hold rating in a research report on Friday, March 1st. UBS Group increased their price objective on Certara from $17.00 to $20.00 and gave the company a neutral rating in a research report on Friday, March 1st. Leerink Partnrs reissued a market perform rating on shares of Certara in a research report on Monday, February 26th. JMP Securities initiated coverage on Certara in a research report on Thursday, April 4th. They issued a market perform rating for the company. Finally, Barclays raised their target price on Certara from $16.00 to $18.00 and gave the stock an equal weight rating in a research report on Thursday, January 25th. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Certara has an average rating of Hold and a consensus target price of $20.06.

Certara Trading Down 4.2 %

NASDAQ:CERT opened at $17.67 on Wednesday. The stock’s 50 day moving average price is $17.83 and its 200 day moving average price is $16.09. Certara has a 52 week low of $11.81 and a 52 week high of $24.96. The company has a market capitalization of $2.83 billion, a P/E ratio of -50.49, a P/E/G ratio of 1.90 and a beta of 1.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62.

Certara (NASDAQ:CERT) last released its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. The firm had revenue of $88.01 million during the quarter, compared to analyst estimates of $86.80 million. On average, research analysts forecast that Certara will post 0.29 EPS for the current fiscal year.

Insiders Place Their Bets

In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now directly owns 173,524 shares in the company, valued at $3,123,432. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now directly owns 173,524 shares in the company, valued at $3,123,432. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Richard M. Traynor sold 6,000 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $18.00, for a total value of $108,000.00. Following the transaction, the senior vice president now owns 165,368 shares of the company’s stock, valued at $2,976,624. The disclosure for this sale can be found here. Insiders sold 23,427 shares of company stock worth $405,095 over the last three months. 2.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Certara

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Tower Research Capital LLC TRC increased its position in Certara by 584.8% in the second quarter. Tower Research Capital LLC TRC now owns 1,356 shares of the company’s stock worth $25,000 after purchasing an additional 1,158 shares during the period. Pineridge Advisors LLC acquired a new stake in Certara in the fourth quarter worth about $28,000. State of Wyoming increased its position in Certara by 103.1% in the second quarter. State of Wyoming now owns 2,027 shares of the company’s stock worth $37,000 after purchasing an additional 1,029 shares during the period. Covestor Ltd increased its position in Certara by 14,940.0% in the third quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after purchasing an additional 3,735 shares during the period. Finally, Advisors Asset Management Inc. increased its position in Certara by 42.9% in the third quarter. Advisors Asset Management Inc. now owns 4,710 shares of the company’s stock worth $68,000 after purchasing an additional 1,414 shares during the period. 73.96% of the stock is currently owned by institutional investors and hedge funds.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.